Work

A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome

Year: 2007

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood-2006-07-035725

Authors: Pierre Fenaux, Azra Raza, Ghulam J. Mufti, Carlo Aul, Ulrich Germing, Hagop Kantarjian, Larry Cripe, René Kerstens, Peter De Porre, Razelle Kurzrock

Institutions: Hôpital Avicenne, Rush University Medical Center, King's College London, Heinrich Heine University Düsseldorf, The University of Texas MD Anderson Cancer Center, Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2024196844

FWCI: 11.29

Cites: 30

Cited by: 104

Related to: 10